Prokidney Corp. SEC filings PROK
Prokidney Corp. has 401 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | May 28, 2026 |
| DEF 14A | Proxy statement | Apr 26, 2024 | May 30, 2024 |
| DEF 14A | Proxy statement | May 26, 2023 | Jun 29, 2023 |
| DEFA14A | Additional proxy material | Jul 11, 2022 | — |
| DEFA14A | Additional proxy material | Jul 6, 2022 | — |
| DEFA14A | Additional proxy material | Jun 23, 2022 | — |
| DEFA14A | Additional proxy material | Jun 15, 2022 | — |
| DEFM14A | Filing | Jun 10, 2022 | — |
| DEFA14A | Additional proxy material | Jun 8, 2022 | — |
| DEFA14A | Additional proxy material | Jun 7, 2022 | — |
| DEFA14A | Additional proxy material | May 26, 2022 | — |
| DEFA14A | Additional proxy material | May 20, 2022 | — |
| DEFA14A | Additional proxy material | May 11, 2022 | — |
| DEFA14A | Additional proxy material | May 3, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEFA14A | Additional proxy material | Apr 18, 2022 | — |
| DEFA14A | Additional proxy material | Apr 12, 2022 | — |
| DEFA14A | Additional proxy material | Mar 28, 2022 | — |
| DEFA14A | Additional proxy material | Mar 1, 2022 | — |
| PREM14A | Filing | Feb 14, 2022 | Feb 14, 2022 |
| DEFA14A | Additional proxy material | Jan 27, 2022 | — |
| DEFA14A | Additional proxy material | Jan 21, 2022 | — |
| DEFA14A | Additional proxy material | Jan 19, 2022 | — |
| DEFA14A | Additional proxy material | Jan 18, 2022 | — |
| DEFA14A | Additional proxy material | Jan 18, 2022 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PROK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Winston-Salem, NC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850270
- Former names
- Social Capital Suvretta Holdings Corp. III (until Jul 11, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.